Nautilus Biotechnology, Inc. (NAUT) Tops Q2 EPS by 3c

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q2 EPS of ($0.12), $0.03 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.

You May Also Be Interested In

• Apple suing OpenAI over alleged misappropriation of trade secrets
• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Niagen Bioscience files to sell up to $50M in common stock